Skip to main content
×
×
Home

Effect of Healthcare-Acquired Infection on Length of Hospital Stay and Cost

  • Nicholas Graves (a1) (a2), Diana Weinhold (a3), Edward Tong (a1), Frances Birrell (a1), Shane Doidge (a1), Prabha Ramritu (a1), Kate Halton (a1) (a2), David Lairson (a4) and Michael Whitby (a1)...
Abstract
Objective.

To estimate the independent effect of a single lower respiratory tract infection, urinary tract infection, or other healthcare-acquired infection on length-of-stay and variable costs and to demonstrate the bias from omitted variables that is present in previous estimates.

Design.

Prospective cohort study.

Setting.

A tertiary care referral hospital and regional district hospital in southeast Queensland, Australia.

Patients.

Adults aged 18 years or older with a minimum inpatient stay of 1 night who were admitted to selected clinical specialities.

Results.

Urinary tract infection was not associated with an increase in length of hospital stay or variable costs. Lower respiratory tract infection was associated with an increase of 2.58 days in the hospital and variable costs of AU$24, whereas other types of infection were associated with an increased length of stay of 2.61 days but not with variable costs. Many other factors were found to be associated with increased length of stay and variable costs alongside healthcare-acquired infection. The exclusion of these variables caused a positive bias in the estimates of the costs of healthcare-acquired infection.

Conclusions.

The existing literature may overstate the costs of healthcare-acquired infection because of bias, and the existing estimates of excess costs may not make intuitive sense to clinicians and policy makers. Accurate estimates of the costs of healthcare-acquired infection should be made and used in appropriately designed decision-analytic economic models (ie, cost-effectiveness models) that will make valid and believable predictions of the economic value of increased infection control.

Copyright
Corresponding author
School of Public Health, Queensland University of Technology, Victoria Park Rd., Kelvin Grove, QLD 4059, Australia (n.graves@qut.edu.au)
References
Hide All
1.Haley, RW. Cost-benefit analysis of infection control activities. In: Brachman, P, Bennett, J, eds. Hospital Infections. Philadelphia, PA: Lippincott-Raven; 1998:249267.
2.Scheckler, WE. Hospital costs of nosocomial infections: a prospective three month study in a community hospital. Infect Control 1980;1:150152.
3.Plowman, RP, Graves, N, Griffin, MAS, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198209.
4.Delgado-Rodriguez, M, Bueno-Cavanillas, A, Lopez-Gigosos, R, et al. Hospital stay length as an effect modifier of other risk factors for nosocomial infection. Eur J Epidemiol 1990;6:3439.
5.Glynn, A, Ward, V, Wilson, Iet al. Hospital Acquired Infection: Surveillance Policies and Practice. London: Public Health Laboratory Service; 1997.
6.Harbarth, S, Sax, H, Gastmeier, P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003;54:258266.
7.Cohen, DR. Economic issues in infection control. J Hosp Infect 1984;5(suppl A):1725.
8.Drummond, MF, Davies, LF. Evaluation of the costs and benefits of reducing hospital infection. J Hosp Infect 1991;18(suppl A):8593.
9.Graves, N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561566.
10.Graves, N, Halton, K, Lairson, D. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol 2007;28:178184.
11.Stone, PW, Braccia, D, Larson, E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005;33:501509.
12.Graves, N, Weinhold, D. Complexity and the attribution of cost to hospital acquired infection. In: Roberts, JA, ed. Economics and Infectious Diseases. Oxford: Oxford University Press; 2006.
13.McGowan, JE Jr. Cost and benefit in control of nosocomial infection: methods for analysis. Rev Infect Dis 1981;3:790797.
14.Katz, MH. Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003;138:644650.
15.Haley, RW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med 1991;91(suppl 3B):32s38s.
16.Freeman, J, McGowan, JE. Risk factors for nosocomial infection. J Infect Dis 1978;138:811819.
17.Ramanathan, R. Introductory Econometrics. 4th ed. San Diego: Dryden Press, 1998.
18.Cooper, BS, Stone, SP, Kibbler, CC, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 2003;7:1194.
19.Graves, N, Weinhold, D, Roberts, JAR. Correcting for bias when estimating the cost of hospital acquired infection: an analysis of lower respiratory tract infections in non-surgical patients. Health Econ 2005;14:755761.
20.Clarke, SKR. Sepsis in surgical wounds, with particular reference to Staphlyococcus aureus. Br J Surg 1957;44:592596.
21.Tambyah, PA, Knasinski, V, Maki, DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 2002;23:2731.
22.Aggarwal, R, Ghoshal, UC, Naik, SR. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol 2003;38:215222.
23.Freeman, J, Rosner, BA, McGowan, JE. Adverse effects of nosocomial infection. J Infect Dis 1979;140:732740.
24.Haley, RW, Schaberg, D, Crossley, K, Von Allmen, S, McGowan, J. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective inter-hospital comparison. Am J Med 1981;70:5158.
25.Pena, C, Pujol, M, Pallares, R, et al. Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs. Medicina Clinica 1996;106:441444.
26.Zhou, Q, Chu, D, Gao, X. A matched case-control study on direct economic costs of four kinds of nosocomial infections [in Chinese]. Zhon-ghua Liu Xing Bing Xue Za Zhi 2001;22:133136.
27.Dietrich, ES, Demmler, M, Schulgen, G, et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection 2002;30:6167.
28.Askarian, M, Gooran, NR. National nosocomial infection surveillance system-based study in Iran: additional hospital stay attributable to nosocomial infections. Am J Infect Control 2003;31:465468.
29.Kappstein, I, Daschner, F. Potential inroads to reducing hospital acquired staphylococcal infection and its cost. J Hosp Infect 1991;19(suppl B):3134.
30.Kappstein, I, Schulgen, G, Beyer, U, Geiger, K, Schumacher, M, Daschner, FD. Prolongation of stay and extra cost due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504508.
31.Rubinstein, E, Green, M, Modan, M, Amit, P, Bernstein, L, Rubenstein, A. The effect of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother 1982;9(suppl A):93100.
32.Givens, CD, Wenzel, RP. Catheter-associated urinary tract infections in surgical patients: a controlled study of the excess morbidity and costs. J Urol 1980;124:646648.
33.Green, M, Rubenstein, E, Amit, P. Estimating the effects of nosocomial infections on the length of hospitalization. J Infect Dis 1982;145:667672.
34.Coello, R, Glenister, H, Fereres, J, et al. The cost of infection in surgical patients: a case control study. J Hosp Infect 1993;25:239250.
35.Medina, M, Martinez-Gallego, G, Sillero-Arenas, M, Delgado-Rodriguez, M. Risk factors and length of stay attributable to hospital infections of the urinary tract in general surgery patients [in Spanish]. Enferm Infecc Microbiol Clin 1997;15:310314.
36.Moris de la Tassa, J, Fernandez Munoz, P, Antuna Egocheaga, A, Gutierrez del Rio, MC, Carton Sanchez, IA. Estimating the costs associated with nosocomial urinary tract infection: a case-control study [in Spanish]. Rev Clin Esp 2003;203:119124.
37.Plowman, R, Graves, N, Griffin, MA, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198209.
38.Warren, DK, Shukla, SJ, Olsen, MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:13121317.
39.Auslab [computer program]. Melbourne, Australia: PJA Computer Consultants; 1999.
40.Jones, FL, McMillan, J. Scoring occupational categories for social research: a review of current practice with Australian examples. Work Employ Soc 2001;15:539563.
41.National Centre for Classification in Health [NCCH]. International Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-W-AM). 3rd ed. Sydney, Australia: NCCH; 2002.
42.Aurich, E, Borgert, J, Butler, M, et al. Introduction to Australian surveillance definitions: surgical site infections and bloodstream infections. Aust Infect Control 2000;5:2531.
43.Manning, WG, Mullahy, I. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461494.
44.Manning, W. RE: inskew question. Stata list server; December 9, 2002. Available at: http://www.stata.com/statalist/archive/2002-12/msg00193.html. Accessed August 2005.
45.McCullagh, P, Neider, IA. Generalized Linear Models. London: Chapman & Hall; 1989.
46.Manning, WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998;17:283295.
47.Basu, A, Manning, WG, Mullahy, J. Comparing alternative models: log vs Cox proportional hazard? Health Econ 2004;13:749765.
48.White, H. A heteroscedasticity-consistent covariance matrix estimator and a direct test for heteroscedasticity. Econometrica 1980;48:817838.
49.Roberts, RR, Frutos, PW, Ciavarella, GC, et al. Distribution of fixed vs variable costs of hospital care. JAMA 1999;281:644649.
50.Plowman, RP, Graves, N, Griffin, M, et al. The Socioeconomic Burden of Hospital Acquired Infection. London: Public Health Laboratory Service; 1999.
51.Dawson, D. Costs and Prices in the Internal Market: Markets vs the NHS Management Executive Guidelines. 1st ed. York: University of York; 1994.
52.Dawson, D, Goddard, M. Longer term agreements for health care services: what will they achieve?Discussion paper 157, Centre for Health Economics. York: University of York; 1998.
53.Harris, J. The internal organisation of hospitals: some economic implications. Bell J Econ 1977;8:467482.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 19 *
Loading metrics...

Abstract views

Total abstract views: 891 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st August 2018. This data will be updated every 24 hours.